Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan
- PMID: 28879394
- DOI: 10.1007/s00259-017-3819-9
Measurement uncertainty and clinical impact of target-to-background ratios derived by interim FDG-PET/CT in Hodgkin lymphoma: reply to Laffon and Martan
Comment on
-
FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET.Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1602-1603. doi: 10.1007/s00259-017-3719-z. Epub 2017 May 18. Eur J Nucl Med Mol Imaging. 2017. PMID: 28523358 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
